Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer.

Woodward, Emma R; van Veen, Elke M; Forde, Claire; Harkness, Elaine F; Byers, Helen J; Ellingford, Jamie M; Burghel, George J; Schlech, Helene; Bowers, Naomi L; Wallace, Andrew J; Howell, Sacha J; Howell, Anthony; Lalloo, Fiona; Newman, William G; Smith, Miriam J; Gareth Evans, D

Woodward, Emma R; van Veen, Elke M; Forde, Claire; Harkness, Elaine F; Byers, Helen J; Ellingford, Jamie M; Burghel, George J; Schlech, Helene; Bowers, Naomi L; Wallace, Andrew J; Howell, Sacha J; Howell, Anthony; Lalloo, Fiona; Newman, William G; Smith, Miriam J; Gareth Evans, D.

Affiliation

Woodward ER; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
van Veen EM; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Forde C; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Harkness EF; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Byers HJ; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Ellingford JM; Prevent Breast Cancer Centre, Wythenshawe Hospital Manchester Universities Foundation Trust, Wythenshawe, Manchester, UK.
Burghel GJ; Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Schlech H; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Bowers NL; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Wallace AJ; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Howell SJ; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Howell A; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Lalloo F; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Newman WG; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Smith MJ; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Gareth Evans D; Prevent Breast Cancer Centre, Wythenshawe Hospital Manchester Universities Foundation Trust, Wythenshawe, Manchester, UK.

Genet Med ; 23(10): 1969-1976, 2021 10.

Article de En | MEDLINE | ID: mdl-34113003

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Tumeurs du sein / Checkpoint kinase 2 / Protéine du groupe de complémentation N de l'anémie de Fanconi Type d'étude: Diagnostic_studies / Etiology_studies Limites: Female / Humans Langue: En Journal: Genet Med Sujet du journal: GENETICA MEDICA Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google